Perfil
Founder of Atreca, Inc., Daniel Emerling is Senior Vice President-Research at this company.
In the past he occupied the position of Senior Director-Pharmacology at Nuon Therapeutics, Inc. and Senior Director-Preclinical Pharmacology at Renovis, Inc.
He received an undergraduate degree from the University of California, Berkeley and a doctorate from Massachusetts Institute of Technology.
Cargos activos de Daniel Emerling
Empresas | Cargo | Inicio |
---|---|---|
ATRECA, INC. | Founder | 11/06/2010 |
Antiguos cargos conocidos de Daniel Emerling.
Empresas | Cargo | Fin |
---|---|---|
Nuon Therapeutics, Inc.
Nuon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nuon Therapeutics Inc. develops therapies to treat inflammation and neurological diseases. The company focuses on the development and commercialization of new therapies for autoimmune disease and inflammation includes rheumatoid arthritis and multiple sclerosis. Nuon Therapeutics was founded by Kim Puloma Kamdar, Marc Feldmann, Lawrence J. Steinman and Michael Selley in 2006 and is headquartered in San Mateo, CA. | Corporate Officer/Principal | 01/01/2011 |
Renovis, Inc.
Renovis, Inc. Pharmaceuticals: MajorHealth Technology Renovis, Inc. develops pharmaceutical products. The company discovers, develops, and commercializes novel therapeutics for neurological and inflammatory diseases. It is headquartered in San Francisco, CA | Corporate Officer/Principal | 01/01/2009 |
Formación de Daniel Emerling.
Massachusetts Institute of Technology | Doctorate Degree |
University of California, Berkeley | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
ATRECA, INC. | Health Technology |
Empresas privadas | 2 |
---|---|
Renovis, Inc.
Renovis, Inc. Pharmaceuticals: MajorHealth Technology Renovis, Inc. develops pharmaceutical products. The company discovers, develops, and commercializes novel therapeutics for neurological and inflammatory diseases. It is headquartered in San Francisco, CA | Health Technology |
Nuon Therapeutics, Inc.
Nuon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nuon Therapeutics Inc. develops therapies to treat inflammation and neurological diseases. The company focuses on the development and commercialization of new therapies for autoimmune disease and inflammation includes rheumatoid arthritis and multiple sclerosis. Nuon Therapeutics was founded by Kim Puloma Kamdar, Marc Feldmann, Lawrence J. Steinman and Michael Selley in 2006 and is headquartered in San Mateo, CA. | Health Technology |